From the Founders

Jeff Morby: The Answers Are Being Revealed

Posted: Nov. 21, 2013

Several weeks ago, the Cure Alzheimer’s Fund (CAF) Executive Committee and staff met with the members of our Research Consortium in Chicago.

Jeff Morby, Chairman and Co-Founder, Wins Rotary Club Award

Posted: Jul. 18, 2013

On May 18 Jeff Morby, chairman and co-founder of Cure Alzheimer’s Fund, was honored with the prestigious Paul Harris Award from Rotary District 7950. Paul Harris founded the Rotary Club more than a century ago and the award was created to recognize those who have made great contributions to society under the Rotary’s motto of “Service Above Self.”

Ninety Seconds with Co-Founder Henry McCance

Posted: May 4, 2013

Henry McCance, chairman emeritus of Greylock Partners, co-founded Cure Alzheimer’s Fund (CAF) in 2005 after getting frustrated with the lack of knowledge about the disease when his wife was diagnosed. He was interviewed by the Boston Business Journal about his venture capital approach to funding Alzheimer's disease research.

BRAIN Initiative and RAND Study: An Assessment

Posted: Apr. 5, 2013

Over the last several days, two important announcements pertaining to Alzheimer's and other neurological diseases have been made.

Can Venture Capital Help Cure Alzheimer's Disease?

Posted: Dec. 13, 2012

A Pittsburgh philanthropist and retired Mellon exec thinks so. In 1988, Jeffrey L. Morby left American Express to join the management team tapped to rescue the nearly bankrupt Mellon Bank. After helping turn Mellon around, he retired at 59, but Morby has hardly been wiling away the time.

Letter from the Chairs

Posted: Dec. 5, 2012

From our 2011 Annual Report.

 

Dear Friends,

On behalf of the Board of Directors and the Research Consortium, we want to thank all the donors, researchers and academic institutional partners supporting Cure Alzheimer’s Fund research for your help in making 2011 such a successful science year. Guided by leading scientists in the field, Cure Alzheimer’s Fund-supported research continues to make breakthrough progress toward our goal of eradicating Alzheimer’s disease.

Board Update 2010: Our work is fueling progress

Posted: Dec. 14, 2010

Our focus on funding high-quality, innovative work is fueling progress in Alzheimer’s research

Dear Friends,

It has been an outstanding year at Cure Alzheimer’s Fund(CAF). Our strategy of using a business and venture approach for funding research is working. We’ve been recognized in The Wall Street Journal, Time magazine and AARP, featured on NPR and CNN.com and invited to exclusive conferences at the White House, TEDMED and the Milken Institute.

Update from the Board: December 2009

Posted: Jan. 4, 2010

Dear Friends,

Why should you care about Alzheimer’s research?

Currently, for every dollar spent on Alzheimer’s care, only a penny is spent working toward a cure. This is a bad equation for a disease that is estimated will cost well more than $100 billion in care (Medicare and Medicaid alone) in 2009.

 

Letter from the Founders - Why You Should Care About Alzheimer's Research

Posted: Dec. 10, 2009

Why should you care about Alzheimer’s research?

Currently, for every dollar spent on Alzheimer's care, only a penny is spent working toward a cure. This is a bad equation for a disease that is estimated to cost more than $100 billion in care (Medicare and Medicaid alone) in 2009.

Cure Alzheimer's Fund Closes 2008 with a Huge Win!

Posted: Aug. 20, 2009

We set out three years ago to jumpstart progress toward a cure for Alzheimer’s disease and we are succeeding.

  • The Alzheimer’s Genome Project™ (AGP), targeting the full set of Alzheimer’s genetic risk factors, identified seventy new genes, a tremendous result and truly breakthrough research.New genes open extensive novel scientific avenues for better understanding the disease and development of effective therapies.
  • Publications announcing these results have begun and findings will continue to be announced in coming months.
  • Other funded work, such as the AlzGene tool which allows researchers around the world to share and analyze information, is driving progress forward in unprecedented ways.

The personal and economic impact of Alzheimer’s is enormous and the path to a cure is through research.